Free tool
Dividend paying stocks
We cover 102 companies that currently pay a dividend. The median market value in the group is $60.58B. Across the group, the median move over the past trading day is +0.10%. 70% of the 100 with a 200-day average trade above it. Price change over the past year runs from −11.2% to +60.0% across the middle 80 percent of the group, with a median of +12.5%.
Other lists in this group
Table
102 of 9,852 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% | Oct 29, 2026 |
| LLY | Eli Lilly and Company | $1.06T | Mega cap | +62.80% | Oct 29, 2026 |
| JNJ | Johnson & Johnson | $658.24B | Mega cap | +55.40% | Oct 13, 2026 |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% | Oct 13, 2026 |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% | Oct 29, 2026 |
| ABBV | AbbVie Inc. | $469.68B | Mega cap | +29.36% | Oct 29, 2026 |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% | Oct 29, 2026 |
| MRK | Merck & Co., Inc. | $377.72B | Mega cap | +86.85% | Oct 29, 2026 |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% | Oct 27, 2026 |
| NVS | Novartis AG | $299.44B | Mega cap | +27.93% | Oct 27, 2026 |
| AZN.L | AstraZeneca PLC | $264.05B | Mega cap | +5.65% | Oct 30, 2026 |
| AZN | AstraZeneca PLC | $263.12B | Mega cap | +5.09% | Oct 30, 2026 |
| AZN.ST | AstraZeneca PLC | $258.56B | Mega cap | +6.22% | Oct 30, 2026 |
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% | Nov 3, 2026 |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% | Nov 3, 2026 |
| TMO | Thermo Fisher Scientific Inc. | $234.31B | Mega cap | +30.17% | Oct 21, 2026 |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% | Oct 21, 2026 |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% | Nov 4, 2026 |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% | Nov 4, 2026 |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% | Nov 4, 2026 |
| NVO | Novo Nordisk A/S | $208.63B | Mega cap | −13.32% | Nov 4, 2026 |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% | Oct 14, 2026 |
| ABT | Abbott Laboratories | $198.74B | Large cap | −11.83% | Oct 14, 2026 |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% | Oct 29, 2026 |
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% | Oct 29, 2026 |
| PFE | Pfizer Inc. | $161.30B | Large cap | +18.72% | Nov 3, 2026 |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% | Nov 3, 2026 |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% | Oct 20, 2026 |
| DHR | Danaher Corporation | $151.40B | Large cap | +5.61% | Oct 20, 2026 |
| BMY | Bristol-Myers Squibb Company | $138.03B | Large cap | +47.01% | Oct 29, 2026 |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% | Oct 29, 2026 |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +34.90% | Oct 29, 2026 |
| SYK | Stryker Corporation | $126.45B | Large cap | −15.52% | Oct 29, 2026 |
| MDT | Medtronic plc | $117.78B | Large cap | +2.29% | Sep 1, 2026 |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% | Sep 1, 2026 |
| SNW.DE | Sanofi | $109.40B | Large cap | −2.82% | Oct 30, 2026 |
| SAN.PA | Sanofi | $109.36B | Large cap | −2.60% | Oct 30, 2026 |
| SNY | Sanofi | $108.83B | Large cap | −4.33% | Oct 30, 2026 |
| MCK | McKesson Corporation | $104.54B | Large cap | +31.57% | Nov 4, 2026 |
| GSK | GSK plc | $104.29B | Large cap | +32.23% | Oct 28, 2026 |
| GSK.L | GSK plc | $104.16B | Large cap | +30.59% | Oct 28, 2026 |
| GS71.DE | GSK plc | $103.63B | Large cap | +34.79% | Oct 28, 2026 |
| HCA | HCA Healthcare, Inc. | $94.76B | Large cap | +5.96% | Oct 23, 2026 |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% | Oct 21, 2026 |
| ELV | Elevance Health, Inc. | $87.30B | Large cap | +32.12% | Oct 21, 2026 |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% | Oct 28, 2026 |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% | Oct 28, 2026 |
| CGN.DE | The Cigna Group | $74.86B | Large cap | −8.78% | Nov 5, 2026 |
| CI | The Cigna Group | $74.22B | Large cap | −4.84% | Nov 5, 2026 |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $71.92B | Large cap | +9.21% | Oct 27, 2026 |
| COR | Cencora, Inc. | $62.55B | Large cap | +13.45% | Nov 4, 2026 |
| TAK | Takeda Pharmaceutical Company Limited | $58.60B | Large cap | +22.68% | Oct 29, 2026 |
| 4502.T | Takeda Pharmaceutical Company Limited | $58.08B | Large cap | +36.03% | Oct 29, 2026 |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% | Nov 3, 2026 |
| BAY.WA | Bayer Aktiengesellschaft | $55.90B | Large cap | +76.59% | Nov 3, 2026 |
| CAH | Cardinal Health, Inc. | $55.45B | Large cap | +61.05% | Nov 5, 2026 |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% | Nov 5, 2026 |
| BDX | Becton, Dickinson and Company | $51.81B | Large cap | +25.97% | Nov 5, 2026 |
| 7741.T | HOYA Corporation | $51.57B | Large cap | +28.99% | Oct 30, 2026 |
| HUM | Humana Inc. | $46.96B | Large cap | +33.14% | Nov 6, 2026 |
| 4578.T | Otsuka Holdings Co., Ltd. | $40.39B | Large cap | +57.62% | Oct 29, 2026 |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% | Nov 4, 2026 |
| 2U3.DE | Alcon Inc. | $35.20B | Large cap | −7.70% | Nov 10, 2026 |
| ALC | Alcon Inc. | $35.13B | Large cap | −10.24% | Nov 10, 2026 |
| RMD | ResMed Inc. | $34.13B | Large cap | −15.77% | Oct 29, 2026 |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% | Oct 28, 2026 |
| 4568.T | Daiichi Sankyo Company, Limited | $32.82B | Large cap | −17.94% | Oct 30, 2026 |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% | Nov 3, 2026 |
| ZTS | Zoetis Inc. | $32.03B | Large cap | −49.50% | Nov 3, 2026 |
| 068270.KS | Celltrion, Inc. | $31.91B | Large cap | +11.19% | Oct 29, 2026 |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% | Nov 4, 2026 |
| LH | Labcorp Holdings Inc. | $27.39B | Large cap | +21.14% | Nov 3, 2026 |
| DGX | Quest Diagnostics Incorporated | $26.99B | Large cap | +38.12% | Oct 20, 2026 |
| 4503.T | Astellas Pharma Inc. | $26.88B | Large cap | +53.57% | Oct 29, 2026 |
| PHG | Koninklijke Philips N.V. | $26.38B | Large cap | +1.27% | Nov 3, 2026 |
| WST | West Pharmaceutical Services, Inc. | $24.63B | Large cap | +42.61% | Oct 22, 2026 |
| 4543.T | Terumo Corporation | $23.67B | Large cap | −2.68% | Nov 11, 2026 |
| STE | STERIS plc | $23.09B | Large cap | −4.41% | Nov 4, 2026 |
| DIM.PA | Sartorius Stedim Biotech S.A. | $21.78B | Large cap | +11.64% | Oct 22, 2026 |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% | Oct 22, 2026 |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% | Nov 5, 2026 |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% | Nov 5, 2026 |
| ZBH | Zimmer Biomet Holdings, Inc. | $19.34B | Large cap | −4.32% | Nov 5, 2026 |
| QS51.DE | Straumann Holding AG | $18.40B | Large cap | −1.10% | Oct 28, 2026 |
| COLO-B.CO | Coloplast A/S | $15.96B | Large cap | −20.60% | Nov 3, 2026 |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +7.91% | Nov 3, 2026 |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% | Oct 22, 2026 |
| 4507.T | Shionogi & Co., Ltd. | $15.45B | Large cap | +15.63% | Oct 29, 2026 |
| FPH.AX | Fisher & Paykel Healthcare Corporation Limited | $15.44B | Large cap | +11.27% | Nov 24, 2026 |
| RDOR3.SA | Rede D'Or São Luiz S.A. | $14.92B | Large cap | +1.37% | Nov 11, 2026 |
| 7733.T | Olympus Corporation | $14.46B | Large cap | +27.06% | Nov 10, 2026 |
| RVTY | Revvity, Inc. | $13.93B | Large cap | +42.93% | Oct 26, 2026 |
| BAX | Baxter International Inc. | $13.70B | Large cap | +8.90% | Oct 29, 2026 |
| ORNBV.HE | Orion Oyj | $13.16B | Large cap | +21.01% | Oct 28, 2026 |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% | Nov 3, 2026 |
| REC.MI | Recordati Industria Chimica e Farmaceutica S.p.A. | $12.57B | Large cap | +1.80% | Nov 10, 2026 |
| FMS | Fresenius Medical Care AG | $12.51B | Large cap | −3.21% | Nov 3, 2026 |
| EHC | Encompass Health Corporation | $11.92B | Large cap | −1.75% | Oct 28, 2026 |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% | Nov 9, 2026 |
| UHS | Universal Health Services, Inc. | $10.53B | Large cap | −1.76% | Oct 26, 2026 |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% | Nov 3, 2026 |
| RDY | Dr. Reddy's Laboratories Limited | $10.18B | Large cap | −14.19% | Oct 22, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.